Search

Author/Creator Larson, Kajal B.

1. Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection. Issue 11 (November 2018)

Authors:
Bradley, John S.; Ang, Jocelyn Y.; Arrieta, Antonio C.; Larson, Kajal B.; Rizk, Matthew L.; Caro, Luzelena; Yang, Shan; Yu, Brian; Johnson, Matthew G.; Rhee, Elizabeth G.
Journal:
Pediatric infectious disease journal
Issue:
Volume 37:Issue 11(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults. (28th January 2015)

Authors:
Larson, Kajal B.; Cressey, Tim R.; Yogev, Ram; Wiznia, Andrew; Hazra, Rohan; Jean-Philippe, Patrick; Graham, Bobbie; Gonzalez, Amy; Britto, Paula; Carey, Vincent J.; Acosta, Edward P.
Journal:
Journal of the Pediatric Infectious Diseases Society
Issue:
Volume 5:Number 2(2016:Jun.)
Page Start:
131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection. (19th January 2017)

Authors:
Boix, Vicente; Fedorak, Richard N.; Mullane, Kathleen M.; Pesant, Yves; Stoutenburgh, Uschi; Jin, Mandy; Adedoyin, Adedayo; Chesnel, Laurent; Guris, Dalya; Larson, Kajal B.; Murata, Yoshihiko
Journal:
Open forum infectious diseases
Issue:
Volume 4:Number 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗